216 related articles for article (PubMed ID: 29200102)
1. Adult Primary Immune Thrombocytopenia: Spleen Histology Findings and Outcomes According to Rituximab Use Based on Analysis of 41 Cases.
Furudoï A; Rivière É; Lazaro E; Furudoï E; Viallard JF; Parrens M
Am J Surg Pathol; 2018 Mar; 42(3):401-412. PubMed ID: 29200102
[TBL] [Abstract][Full Text] [Related]
2. B cell depleting therapy regulates splenic and circulating T follicular helper cells in immune thrombocytopenia.
Audia S; Rossato M; Trad M; Samson M; Santegoets K; Gautheron A; Bekker C; Facy O; Cheynel N; Ortega-Deballon P; Boulin M; Berthier S; Leguy-Seguin V; Martin L; Ciudad M; Janikashvili N; Saas P; Radstake T; Bonnotte B
J Autoimmun; 2017 Feb; 77():89-95. PubMed ID: 27863820
[TBL] [Abstract][Full Text] [Related]
3. Histology of the spleen in immune thrombocytopenia: clinical-pathological characterization and prognostic implications.
Pizzi M; Friziero A; Vianello F; Binotto G; Da Dalt G; Zoletto S; Carraro E; Fassan M; Sbaraglia M; Sperti C; Baldan N; D'Amore F; Bertozzi I; Righi S; Pierobon ES; Moletta L; Capovilla G; Grego A; Sabattini E; Fabris F; Merigliano S; Dei Tos AP
Eur J Haematol; 2021 Feb; 106(2):281-289. PubMed ID: 33190299
[TBL] [Abstract][Full Text] [Related]
4. Immunologic effects of rituximab on the human spleen in immune thrombocytopenia.
Audia S; Samson M; Guy J; Janikashvili N; Fraszczak J; Trad M; Ciudad M; Leguy V; Berthier S; Petrella T; Aho-Glélé S; Martin L; Maynadié M; Lorcerie B; Rat P; Cheynel N; Katsanis E; Larmonier N; Bonnotte B
Blood; 2011 Oct; 118(16):4394-400. PubMed ID: 21876120
[TBL] [Abstract][Full Text] [Related]
5. Increased number of B-cells in the red pulp of the spleen in ITP.
Olsson B; Ridell B; Jernås M; Wadenvik H
Ann Hematol; 2012 Feb; 91(2):271-7. PubMed ID: 21785982
[TBL] [Abstract][Full Text] [Related]
6. B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells.
Mahévas M; Patin P; Huetz F; Descatoire M; Cagnard N; Bole-Feysot C; Le Gallou S; Khellaf M; Fain O; Boutboul D; Galicier L; Ebbo M; Lambotte O; Hamidou M; Bierling P; Godeau B; Michel M; Weill JC; Reynaud CA
J Clin Invest; 2013 Jan; 123(1):432-42. PubMed ID: 23241960
[TBL] [Abstract][Full Text] [Related]
7. Preferential splenic CD8(+) T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia.
Audia S; Samson M; Mahévas M; Ferrand C; Trad M; Ciudad M; Gautheron A; Seaphanh F; Leguy V; Berthier S; Salles B; Martin L; Lorcerie B; Ortega-Deballon P; Facy O; Caillot D; Soudry-Faure A; Michel M; Godeau B; Larmonier N; Saas P; Janikashvili N; Bonnotte B
Blood; 2013 Oct; 122(14):2477-86. PubMed ID: 23963041
[TBL] [Abstract][Full Text] [Related]
8. The spleen dictates platelet destruction, anti-platelet antibody production, and lymphocyte distribution patterns in a murine model of immune thrombocytopenia.
Aslam R; Kapur R; Segel GB; Guo L; Zufferey A; Ni H; Semple JW
Exp Hematol; 2016 Oct; 44(10):924-930.e1. PubMed ID: 27417974
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of spleen pathology in drug abusers with thrombocytopenia related to human immunodeficiency virus infection and in patients with idiopathic thrombocytopenic purpura. A morphometric, immunohistochemical, and ultrastructural study.
Marti M; Feliu E; Campo E; Palacin A; Berga L; Casals FJ; Urbano Ispizua A; Cardesa A; Rozman C
Am J Clin Pathol; 1993 Dec; 100(6):633-42. PubMed ID: 8249910
[TBL] [Abstract][Full Text] [Related]
11. Reemergence of Splenectomy for ITP Second-line Treatment?
Chater C; Terriou L; Duhamel A; Launay D; Chambon JP; Pruvot FR; Rogosnitzky M; Zerbib P
Ann Surg; 2016 Nov; 264(5):772-777. PubMed ID: 27741009
[TBL] [Abstract][Full Text] [Related]
12. Current therapies in primary immune thrombocytopenia.
Pels SG
Semin Thromb Hemost; 2011 Sep; 37(6):621-30. PubMed ID: 22102265
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults.
Kikuchi K; Miyakawa Y; Ikeda S; Sato Y; Takebayashi T
BMC Health Serv Res; 2015 Jan; 15():2. PubMed ID: 25609557
[TBL] [Abstract][Full Text] [Related]
14. [Prediction of the splenectomy efficacy in chronic immune thrombocytopenic purpura].
Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Bosnjaković V
Glas Srp Akad Nauka Med; 2005; (48):119-35. PubMed ID: 16405235
[TBL] [Abstract][Full Text] [Related]
15. Identification of a morphometrical parameter that predicts the response to splenectomy in patients with idiopathic thrombocytopenic purpura.
Bakkaloglu H; Dinccag A; Yanar H; Tunca F; Dogan O; Cermik H; Kucukkaya R
Tohoku J Exp Med; 2006 Sep; 210(1):49-55. PubMed ID: 16960345
[TBL] [Abstract][Full Text] [Related]
16. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
[TBL] [Abstract][Full Text] [Related]
17. The spleen and splenectomy in immune (idiopathic) thrombocytopenic purpura.
Sandler SG
Semin Hematol; 2000 Jan; 37(1 Suppl 1):10-2. PubMed ID: 10676918
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic splenectomy for medically refractory immune thrombocytopenia (ITP): a retrospective cohort study on longtime response predicting factors based on consensus criteria.
Rijcken E; Mees ST; Bisping G; Krueger K; Bruewer M; Senninger N; Mennigen R
Int J Surg; 2014 Dec; 12(12):1428-33. PubMed ID: 25448666
[TBL] [Abstract][Full Text] [Related]
19. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
Schweizer C; Reu FJ; Ho AD; Hensel M
Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
[TBL] [Abstract][Full Text] [Related]
20. ITP and international guidelines: what do we know, what do we need?
Rodeghiero F; Ruggeri M
Presse Med; 2014 Apr; 43(4 Pt 2):e61-7. PubMed ID: 24656296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
